FCX shows a higher anti-obesity effect when it is administered together with medium-chain triacylglycerols (MCT) than FCX alone in diabetic/obese KK-Ay mice with increased expression of Ucp1 in WAT [28]. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.